Evidence map›Paper›PMID 32416313›Full record

ArticleMolecular metabolism2020

The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis.

Gaelle R Carrat, Elizabeth Haythorne, Alejandra Tomas, Leena Haataja, Andreas Müller, Peter Arvan, Alexandra Piunti, Kaiying Cheng, Mutian Huang, Timothy J Pullen and 21 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. DNA Methylation Variation in Blood Cells may Impact Platelet Function.TH open : companion journal to thrombosis and haemostasis · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 6 countries.

Gaelle R CarratSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Elizabeth HaythorneSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Alejandra TomasSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Leena HaatajaDivision of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Andreas MüllerMolecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany; Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Alexandra PiuntiSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Lille 1 University-Science and Technology, Cité Scientifique, 59655, Villeneuve d'Ascq Cedex, France.
Kaiying ChengSection of Structural Biology, Department of Medicine, Imperial College London, London, UK.
Mutian HuangSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Timothy J PullenSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Department of Diabetes, Faculty of Life Science and Medicine, King's College London, London, UK.
Eleni GeorgiadouSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Theodoros StylianidesLoughborough University, Centre of Innovative and Collaborative Construction Engineering, Leicestershire, LE11 3TU, UK.
Nur Shabrina AmirruddinStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), A∗STAR, Proteos, Singapore, 138673, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.
Victoria SalemSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Section of Investigative Medicine, Department of Medicine, Imperial College London, du Cane Road, London, W12 0NN, UK.
Walter DistasoImperial College Business School, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Andrew CakebreadLondon Metallomics Facility, King's College London, Strand, London, WC2R 2LS, UK.
Kate J HeesomProteomics Facility, University of Bristol, Bristol, UK.
Philip A LewisProteomics Facility, University of Bristol, Bristol, UK.
David J HodsonCentre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, UK; Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, Midlands, UK.
Linford J BriantOxford Centre for Diabetes, Endocrinology, and Metabolism, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Annie C H FungDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
Richard B SessionsSchool of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, BS8 1TD, UK.
Fabien AlpyInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM) U1258, Centre National de la Recherche Scientifique (CNRS), UMR 7104, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch, France.
Alice P S KongDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
Peter I BenkeSingapore Lipidomics Incubator, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Mdical Drive, Singapore, 117596, Singapore.
Federico TortaSingapore Lipidomics Incubator, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Mdical Drive, Singapore, 117596, Singapore.
Adrian Kee Keong TeoStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), A∗STAR, Proteos, Singapore, 138673, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore.
Isabelle LeclercSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
Michele SolimenaMolecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany; Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany.
Dale B WigleySection of Structural Biology, Department of Medicine, Imperial College London, London, UK.
Guy A RutterSection of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK. Electronic address: g.rutter@imperial.ac.uk.
Imperial College London · GBNational University of Singapore · SGUniversity of Bristol · GBChinese University of Hong Kong · HKDeutsches Diabetes-Zentrum e.V. · DEKing's College London · GBUniversity of Michigan · USCentre National de la Recherche Scientifique · FRChurchill Hospital · GBLondon Metropolitan University · GBLoughborough University · GBUniversité de Lille · FRUniversity of Nottingham · GB

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Biotechnology and Biological Sciences Research Council BB/L015129/1Cancer Research UKDiabetes UK 12/0004431Diabetes UK 16/0005485Medical Research Council MR/J0003042/1Medical Research Council MR/K001981/1Medical Research Council MR/K023667/1Medical Research Council MR/L020149/1Medical Research Council MR/L02036X/1Medical Research Council MR/M012646/1Medical Research Council MR/N00275X/1Medical Research Council MR/N009258/1Medical Research Council MR/N020472/1Medical Research Council MR/R010676/1Medical Research Council MR/R022259/1Medical Research Council MR/S025618/1Medical Research Council MR/T002107/1NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK048280Wellcome Trust 104931/Z/14/ZWellcome Trust 201325/Z/16/ZWellcome Trust 202902/Z/16/ZWellcome Trust 212625/Z/18/ZWellcome Trust WT098424AIA
6 · The paper itself

Abstract

objectiveRisk alleles for type 2 diabetes at the STARD10 locus are associated with lowered STARD10 expression in the β-cell, impaired glucose-induced insulin secretion, and decreased circulating proinsulin:insulin ratios. Although likely to serve as a mediator of intracellular lipid transfer, the identity of the transported lipids and thus the pathways through which STARD10 regulates β-cell function are not understood. The aim of this study was to identify the lipids transported and affected by STARD10 in the β-cell and the role of the protein in controlling proinsulin processing and insulin granule biogenesis and maturation.

methodsWe used isolated islets from mice deleted selectively in the β-cell for Stard10 (βStard10KO) and performed electron microscopy, pulse-chase, RNA sequencing, and lipidomic analyses. Proteomic analysis of STARD10 binding partners was executed in the INS1 (832/13) cell line. X-ray crystallography followed by molecular docking and lipid overlay assay was performed on purified STARD10 protein.

resultsβStard10KO islets had a sharply altered dense core granule appearance, with a dramatic increase in the number of "rod-like" dense cores. Correspondingly, basal secretion of proinsulin was increased versus wild-type islets. The solution of the crystal structure of STARD10 to 2.3 Å resolution revealed a binding pocket capable of accommodating polyphosphoinositides, and STARD10 was shown to bind to inositides phosphorylated at the 3' position. Lipidomic analysis of βStard10KO islets demonstrated changes in phosphatidylinositol levels, and the inositol lipid kinase PIP4K2C was identified as a STARD10 binding partner. Also consistent with roles for STARD10 in phosphoinositide signalling, the phosphoinositide-binding proteins Pirt and Synaptotagmin 1 were amongst the differentially expressed genes in βStard10KO islets.

conclusionOur data indicate that STARD10 binds to, and may transport, phosphatidylinositides, influencing membrane lipid composition, insulin granule biosynthesis, and insulin processing.

Indexed as

AllelesAnimalsCarrier ProteinsDiabetes Mellitus, Type 2Disease Models, AnimalFemaleInsulinInsulin-Secreting CellsInsulin SecretionLipid MetabolismLipidsMaleMiceMice, Inbred C57BLMice, KnockoutMolecular Docking SimulationCarrier ProteinsInsulinLipidsPhosphatidylinositolsPhosphoproteinsStard10 protein, mouseInsulin granule biogenesisLipid transporterPancreatic β-cellPhosphoinositidesType 2 diabetes

Identifiers

PMID32416313
PMCPMC7322359
OpenAlexW3026026716

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.